Histostem Participates in Successful Stem Cell Treatment for Acute Spinal Cord Injury in Dogs
TAMPA, FL–(Marketwire – 02/08/10) – Stem Cell Therapy International, Inc. (OTC.BB: SCII – News ) announced that Histostem Ltd. of South Korea (”Histostem”) has participated in a study resulting in the successful treatment of spinal cord injury in dogs through the use of Multipotent Stem Cells (MSCs) derived from Human Umbilical Cord Blood (HUCB). The study, a collaborative effort between a team …
[Read the full article here]Related News:
Histostem Participates In Clinical Trials Demonstrating The Effective Use Of Its Proprietary Stem Cells In The Treatment Of Cirrhosis Of The Liver
Stem Cell Administration Study Demonstrates Improved Quality Of Life For Patients Suffering From Spinal Cord Injury
Potential Treatment For Spinal Cord Injury Using Multiple Route Bone Marrow Stem Cell Injections